Free Trial

Joint (NASDAQ:JYNT) Shares Cross Below 200-Day Moving Average - What's Next?

Joint logo with Medical background

The Joint Corp. (NASDAQ:JYNT - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.27 and traded as low as $10.85. Joint shares last traded at $11.11, with a volume of 24,925 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. StockNews.com upgraded Joint from a "hold" rating to a "buy" rating in a research report on Friday, November 15th. Roth Mkm dropped their price target on shares of Joint from $16.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, November 8th.

Get Our Latest Stock Analysis on Joint

Joint Stock Down 1.3 %

The stock has a market cap of $164.37 million, a price-to-earnings ratio of -9.75 and a beta of 1.57. The company's 50-day simple moving average is $11.36 and its 200-day simple moving average is $12.24.

Hedge Funds Weigh In On Joint

A number of institutional investors have recently bought and sold shares of JYNT. Clayton Partners LLC boosted its holdings in shares of Joint by 38.1% in the second quarter. Clayton Partners LLC now owns 186,500 shares of the company's stock worth $2,622,000 after buying an additional 51,500 shares during the period. American Century Companies Inc. lifted its position in shares of Joint by 47.7% in the 2nd quarter. American Century Companies Inc. now owns 24,170 shares of the company's stock valued at $340,000 after acquiring an additional 7,804 shares in the last quarter. Los Angeles Capital Management LLC acquired a new position in Joint in the 2nd quarter worth approximately $1,115,000. Dimensional Fund Advisors LP grew its position in Joint by 9.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company's stock worth $2,730,000 after purchasing an additional 17,268 shares in the last quarter. Finally, O Brien Greene & Co. Inc raised its stake in Joint by 0.9% during the 2nd quarter. O Brien Greene & Co. Inc now owns 115,620 shares of the company's stock valued at $1,626,000 after purchasing an additional 1,000 shares during the period. Hedge funds and other institutional investors own 76.88% of the company's stock.

Joint Company Profile

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Further Reading

Should you invest $1,000 in Joint right now?

Before you consider Joint, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.

While Joint currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines